文献速递心外重症与机械循环支持

持续流心室辅助装置支持期间卒中的影响:STS INTERMACS分析

Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis.
PubMed 文献 · J Heart Lung Transplant · 2020-04-21

基于STS INTERMACS数据库2014年6月至2017年6月共9,489例接受10,285台持续流左心室辅助装置(LVAD)的患者,随访至2018年6月。随访期间1,515例(16%)发生至少1次卒中,缺血性与出血性频率接近。卒中后死亡率明显升高,出血性卒中后6个月生存率<50%,致残性卒中者1年和2年生存显著更差。

要点

  • 持续流LVAD患者卒中风险第1个月约4%、6个月9%、1年14%
  • 出血性卒中后6个月生存率<50%,缺血性卒中为70%
  • 致残性卒中者1年和2年生存显著差于非致残性卒中

核心结论

  • 持续流LVAD支持期间卒中发生率高,致残性卒中与1年和2年死亡率大幅增加相关。

研究设计与样本

  • 回顾性队列分析,基于STS INTERMACS数据库2014年6月至2017年6月9,489例患者共10,285台持续流LVAD,随访至2018年6月。

主要发现

  • 随访期间1,515例(16%)发生1次以上卒中,缺血性与出血性频率接近。
  • 卒中风险第1个月约4%、前6个月9%、第1年14%。
  • 多变量风险函数分析显示早期主要危险因素为离心流装置和同期心脏手术,长期阶段反复不依从史与卒中事件最相关。
  • 调节更新模型显示缺血性卒中尤其是出血性卒中为后续死亡的主要危险因素。
  • 缺血性卒中后6个月生存率70%,出血性卒中后<50%;致残性卒中者1年和2年生存显著更差。

关键数值与推荐

  • 持续流LVAD患者2年内卒中发生率约20%(轴向流与混合悬浮离心流泵)。
  • 缺血性卒中后6个月生存率70%,出血性卒中后6个月生存率<50%。

临床怎么用

  • LVAD患者应重视卒中风险分层与早期预防,尤其关注离心流装置、同期心脏手术及不依从史者。
  • 卒中后需评估致残程度(改良Rankin评分),出血性卒中及致残性卒中预后更差,应加强监护与干预。

局限性

  • 需更完整的改良Rankin评分和卒中恢复期生活质量数据,以理解卒中影响及预防干预策略效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Adverse events, especially strokes, during the implantation of continuous flow durable left ventricular assist devices (LVADs) remain the major barriers to greater application among patients with ambulatory advanced heart failure. METHODS: Between June 2014 and June 2017, a total of 9,489 patients in the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support database received 10,285 continuous flow LVADs, with follow-up through June 2018. RESULTS: During the follow-up period, 1,515 (16%) patients suffered 1 or more strokes, with a nearly equal frequency of ischemic and hemorrhagic etiology. The risk of stroke was about 4% in the first month, 9% during the first 6 months, and 14% in the first year. By multivariable hazard function analysis, the major risk factors identified in the early phase were LVAD centrifugal flow device and concomitant cardiac surgery, whereas in the constant phase (longer term), a history of repeated non-compliance was most associated with a stroke event. Using a modulated renewal model, the occurrence of an ischemic and especially a hemorrhagic stroke dominated as risk factors for subsequent mortality. Six-month survival after an ischemic stroke was 70%, and after a hemorrhagic stroke, it was <50%. Disabling stroke as judged by Modified Rankin Score was associated with significantly worse survival at 1 and 2 years compared with strokes with mild or no early disability. CONCLUSIONS: This study confirms the 20% incidence of stroke over the first 2 years with axial flow and hybrid (magnetic and hydrodynamic) levitated centrifugal flow pumps. This study suggests a major increase in 1- and 2-year mortality among those with an initial disabling vs non-disabling stroke. To better understand the impact of strokes after implantation and the effect of prevention and intervention strategies, we need more complete Modified Rankin Scores and quality of life data during the stroke recovery period.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Kirklin JK, Naftel DC, Myers SL, et al. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis. J Heart Lung Transplant. 2020. PMID: 32376278. doi:10.1016/j.healun.2020.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。